Mercia Fund Management backs InoCardia
Technology investor Mercia Fund Management has backed InoCardia, a UK-based Coventry University spinout providing drug screening services. Mercia Fund Management’s investment will fund the development and commercialisation of a pre-clinical drug testing service for pharmaceutical organisations.
22 July 2014•4 mins read
